# Efficacy and Pathophysiological Implications of a New Asphyxiation Delaying Device

> **NCT05779540** · NA · UNKNOWN · sponsor: **Institute of Mountain Emergency Medicine** · enrollment: 26 (estimated)

## Conditions studied

- Avalanche, Landslide, or Mudslide
- Asphyxia; Immersion

## Interventions

- **DEVICE:** Safeback SBX
- **DEVICE:** Sham device

## Key facts

- **NCT ID:** NCT05779540
- **Lead sponsor:** Institute of Mountain Emergency Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-15
- **Primary completion:** 2023-04
- **Final completion:** 2024-02
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2023-03-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05779540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05779540, "Efficacy and Pathophysiological Implications of a New Asphyxiation Delaying Device". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05779540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*